Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Star
642.0500 1.40 (0.22%)
NSE Jun 06, 2025 15:31 PM
Volume: 1.7M
 

logo
Laurus Labs Ltd.
29 Apr 2024
642.05
0.22%
KRChoksey
Laurus Labs (LAURUSLABS) met our estimates on revenue, EBITDA margins and PAT front for both Q4FY24 and FY24; however, underperformed on GPM in Q4FY24 and marginally underperformed on the same in FY24. Notably, higher value CDMO and custom synthesis segment witnessed 3.5% Y-o-Y (+11.3% Q-o-Q) rise in revenue in Q4FY24 after 4 consecutive quarters of decline seen due to waning of high base effect.
Laurus Labs Ltd. is trading above all available SMAs
More from Laurus Labs Ltd.
Recommended